Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Depreciation & Amortization (IS)EBIATGross ProfitLong-Term Debt IssuancesReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Skinvisible (SKVI) Cost of Revenue (2016 - 2022)

Skinvisible's Cost of Revenue history spans 13 years, with the latest figure at $3300.0 for Q3 2022.

  • On a quarterly basis, Cost of Revenue changed N/A to $3300.0 in Q3 2022 year-over-year; TTM through Jun 2023 was $3300.0, a 118.83% increase, with the full-year FY2022 number at $4808.0, up 45.7% from a year prior.
  • Cost of Revenue hit $3300.0 in Q3 2022 for Skinvisible, up from $1508.0 in the prior quarter.
  • Over the last five years, Cost of Revenue for SKVI hit a ceiling of $10352.0 in Q4 2019 and a floor of -$110970.0 in Q2 2020.
  • Historically, Cost of Revenue has averaged -$4413.4 across 5 years, with a median of $3300.0 in 2021.
  • Biggest five-year swings in Cost of Revenue: surged 4381.39% in 2019 and later crashed 1788.27% in 2020.
  • Tracing SKVI's Cost of Revenue over 5 years: stood at $231.0 in 2018, then surged by 4381.39% to $10352.0 in 2019, then plummeted by 47.3% to $5455.0 in 2020, then crashed by 39.51% to $3300.0 in 2021, then changed by 0.0% to $3300.0 in 2022.
  • Business Quant data shows Cost of Revenue for SKVI at $3300.0 in Q3 2022, $1508.0 in Q1 2022, and $3300.0 in Q1 2021.